Bioverativ Inc (BIVV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIVV | AMGN | VRTX | REGN | BMY |
| Company | Bioverativ Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 104.97 | 315.28 | 442.00 | 969.27 | 44.30 |
| High | 105.01 | 315.28 | 446.10 | 982.77 | 44.30 |
| Low | 104.97 | 310.37 | 440.35 | 966.00 | 43.73 |
| Last | 104.98 | 312.47 | 445.21 | 982.29 | 44.03 |
| Change | +0.33 | -2.25 | +4.57 | +14.31 | -0.08 |
| % Change | +0.32% | -0.71% | +1.04% | +1.48% | -0.18% |
| Volume | 792,900 | 1,971,450 | 1,345,706 | 386,457 | 15,411,139 |
| 20-Day Average Volume | 2,587,600 | 2,910,823 | 1,120,545 | 455,813 | 14,952,167 |
| Previous Close | 104.65 | 314.72 | 440.64 | 967.98 | 44.11 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 104.18 | 293.57 | 412.42 | 939.27 | 45.04 |
| 20-Day Raw Stochastic | 98.80% | 82.19% | 98.36% | 94.14% | 11.19% |
| 20-Day Relative Strength | 86.97% | 63.74% | 72.10% | 61.09% | 33.86% |
| Weighted Alpha | +58.00 | +38.84 | +33.13 | +30.85 | -34.28 |
| Today's Opinion | N/A | 72% Buy | 72% Buy | 72% Buy | 100% Sell |
| Previous Opinion | N/A | 72% Buy | 72% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | N/A | 56% Sell | 8% Buy | 24% Buy | 72% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.30% since 03/01/18 | +0.75% since 05/10/24 | +5.31% since 05/10/24 | +0.87% since 05/10/24 | -2.02% since 05/10/24 |
| Low | 104.14 on 03/06/18 | 307.06 on 05/13/24 | 422.44 on 05/14/24 | 966.00 on 05/17/24 | 43.68 on 05/16/24 |
| High | 105.01 on 03/08/18 | 321.44 on 05/15/24 | 446.10 on 05/17/24 | 988.96 on 05/15/24 | 45.72 on 05/14/24 |
| 1-Month | |||||
| %Chg | +1.78% since 02/08/18 | +18.33% since 04/17/24 | +13.26% since 04/17/24 | +9.00% since 04/17/24 | -7.96% since 04/17/24 |
| Low | 102.51 on 02/09/18 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 105.01 on 03/08/18 | 322.60 on 05/03/24 | 446.10 on 05/17/24 | 988.96 on 05/15/24 | 49.56 on 04/22/24 |
| 3-Month | |||||
| %Chg | +103.96% since 12/08/17 | +10.14% since 02/16/24 | +5.45% since 02/16/24 | +3.61% since 02/16/24 | -11.69% since 02/16/24 |
| Low | 51.25 on 12/11/17 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 105.01 on 03/08/18 | 322.60 on 05/03/24 | 446.10 on 05/17/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +83.92% since 09/08/17 | +17.74% since 11/17/23 | +27.02% since 11/17/23 | +22.41% since 11/17/23 | -13.39% since 11/17/23 |
| Low | 48.28 on 12/01/17 | 260.52 on 11/21/23 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 43.33 on 05/02/24 |
| High | 105.01 on 03/08/18 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,360,936 | 168,826,816 | 113,708,480 | 106,657,832 | 89,415,376 |
| Shares Outstanding, K | 108,220 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 1,168,500,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | 355,600,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 328,700,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | 96,300,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | N/A | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.95 on 02/13/18 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/02/18 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 38.05 | 17.13 | 29.05 | 26.36 | 42.43 |